BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30625389)

  • 1. Clinical Outcomes and Healthcare Resource Utilization for Gastrointestinal Acute Graft-versus-Host Disease after Allogeneic Transplantation for Hematologic Malignancy: A Retrospective US Administrative Claims Database Analysis.
    Johnson BH; Taylor A; Kim G; Drahos J; Yang J; Akbari M; Shah NN
    Biol Blood Marrow Transplant; 2019 Apr; 25(4):834-841. PubMed ID: 30625389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity of Acute Graft-versus-Host Disease and Associated Healthcare Resource Utilization, Cost, and Outcomes.
    Farhadfar N; Leather HL; Wang S; Burton N; IrizarryGatell V; Itzler R; Salloum RG; Wingard JR
    Transplant Cell Ther; 2021 Dec; 27(12):1007.e1-1007.e8. PubMed ID: 34537422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality, length of stay and costs associated with acute graft-versus-host disease during hospitalization for allogeneic hematopoietic stem cell transplantation.
    Yu J; Parasuraman S; Shah A; Weisdorf D
    Curr Med Res Opin; 2019 Jun; 35(6):983-988. PubMed ID: 30461314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Effectiveness of Vedolizumab in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease: A Retrospective Record Review.
    Fløisand Y; Lazarevic VL; Maertens J; Mattsson J; Shah NN; Zachée P; Taylor A; Akbari M; Quadri S; Parfionovas A; Chen YB
    Biol Blood Marrow Transplant; 2019 Apr; 25(4):720-727. PubMed ID: 30468919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare resource utilization and costs associated with acute graft-versus-host disease following allogeneic hematopoietic cell transplantation.
    Yu J; Lal L; Anderson A; DuCharme M; Parasuraman S; Weisdorf D
    Support Care Cancer; 2020 Nov; 28(11):5491-5499. PubMed ID: 32172407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGvHD.
    He F; Warlick E; Miller JS; MacMillan M; Verneris MR; Cao Q; Weisdorf D
    Bone Marrow Transplant; 2016 Aug; 51(8):1107-12. PubMed ID: 27064686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
    Hosoba S; Waller EK; Shenvi N; Graiser M; Easley KA; Al-Kadhimi Z; Andoh A; Antun AG; Barclay S; Josephson CD; Koff JL; Khoury HJ; Langston AA; Zimring JC; Roback JD; Giver CR
    Biol Blood Marrow Transplant; 2018 May; 24(5):973-982. PubMed ID: 29307717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical characteristics of acute graft-versus-host disease confined solely to gastrointestinal tract after allogeneic hematopoietic stem cell transplantation].
    Feng R; Liu DH; Xu LP; Chen H; Zhang XH; Han W; Zhao T; Liu KY; Huang XJ
    Zhonghua Nei Ke Za Zhi; 2010 Dec; 49(12):1028-31. PubMed ID: 21211361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.
    Modi A; Rybicki L; Majhail NS; Mossad SB
    Transpl Infect Dis; 2020 Feb; 22(1):e13217. PubMed ID: 31769584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of the level of Reg3α protein in plasma with gastrointestinal acute graft-versus-host disease].
    Cai CS; Chen GH; Sun AN; Qiao M; Liu HW; Chen F; Wang Y; Qiu HY; Han Y; Ma X; Tang XW; Jin ZM; Fu CC; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):785-90. PubMed ID: 24989295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Economic Burden Associated With Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation in Germany.
    Holtick U; Quignot N; Kapso-Kapnang R; Reichenbach D; Kelly M; Burrell A; Zhang X; Thiruvillakkat K
    Transplant Proc; 2024; 56(1):191-200. PubMed ID: 38199852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute gastrointestinal graft-versus-host disease in pediatric patients: serum albumin on day 5 from initiation of therapy correlates with nonrelapse mortality and overall survival.
    Goussetis E; Paisiou A; Kitra V; Peristeri I; Vessalas G; Stefanaki K; Panayotou I; Giamaiou K; Kontou E; Kitzoni M; Dimopoulou MN; Karkelis S; Kafritsa Y; Rapsomaniki E; Papassotiriou I; Tsirigotis P; Roma E; Graphakos S
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1058-66. PubMed ID: 21073975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States.
    McGuirk J; Divine C; Moon SH; Chandak A; Zhang Z; Papanicolaou GA
    Transplant Cell Ther; 2021 Jun; 27(6):505.e1-505.e9. PubMed ID: 33775616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of graft versus host disease and cytomegalovirus infection in patients post-haematopoietic cell transplantation presenting with gastrointestinal symptoms.
    Liu A; Meyer E; Johnston L; Brown J; Gerson LB
    Aliment Pharmacol Ther; 2013 Oct; 38(8):955-66. PubMed ID: 24003975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Role of Gastrointestinal Endoscopy in the Management of Gastrointestinal Acute GVHD in Children After Hematopoietic Stem Cell Transplantation.
    Gassas A; Krueger J; Schechter T; Zaidman I; Asim M; Ali M
    J Pediatr Hematol Oncol; 2016 Aug; 38(6):453-6. PubMed ID: 27164524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation of the potential association between gastrointestinal viral and bacterial infection and development of intestinal acute graft versus host disease following allogeneic hematopoietic stem cell transplantation.
    Bueno F; Albert E; Giménez E; Piñana JL; Pérez A; Dolores Gómez M; Hernández-Boluda JC; Gonzalez-Barberá EM; Montoro J; Buesa J; Guerreiro M; Balaguer-Roselló A; Hernani R; Sanz J; Solano C; Navarro D
    J Med Virol; 2021 Aug; 93(8):4773-4779. PubMed ID: 33605457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and Outcomes of Bacterial Bloodstream Infections during Acute Graft-versus-Host Disease Involving the Gastrointestinal Tract after Hematopoietic Cell Transplantation.
    Petersen J; Lindner C; Hakki M
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1648-1653. PubMed ID: 31002988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of 104 patients with hematological malignancy after allogeneic hemotopoietic stem cell transplantation].
    Chen Y; Xu Y; Zhu Y; Fu G; Liu Y; Peng J; Fu B; He Q; Wu D; Li X; Zhao X; Chen F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 36(9):859-64. PubMed ID: 21946205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Antibiotic Exposure and Development of Acute Graft-vs-Host Disease Following Allogeneic Hematopoietic Cell Transplantation.
    Rashidi A; Gao F; Fredricks DN; Pergam SA; Mielcarek M; Milano F; Sandmaier BM; Lee SJ
    JAMA Netw Open; 2023 Jun; 6(6):e2317188. PubMed ID: 37285153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease.
    Miller HK; Braun TM; Stillwell T; Harris AC; Choi S; Connelly J; Couriel D; Goldstein S; Kitko CL; Magenau J; Pawarode A; Reddy P; Riwes M; Yanik GA; Levine JE
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):522-528. PubMed ID: 28017733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.